Adagrasib with or without cetuximab in patients with KRASG12C-mutated colorectal cancer (CRC): Analysis of tumor biomarkers and genomic alterations Meeting Abstract


Authors: Pelster, M. S.; Yaeger, R.; Klempner, S. J.; Ou, S. H. I.; Spira, A. I.; Jänne, P. A.; Uboha, N. V.; Gaffar, Y. A.; Newman, G.; Paweletz, C. P.; Heavey, G. A.; Alejandro, L.; Kheoh, T.; Anderes, K.; Torossian, H. D.; Christensen, J. G.; Weiss, J.
Abstract Title: Adagrasib with or without cetuximab in patients with KRASG12C-mutated colorectal cancer (CRC): Analysis of tumor biomarkers and genomic alterations
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S410
Language: English
ACCESSION: WOS:001087480200536
DOI: 10.1016/j.annonc.2023.09.1740
PROVIDER: wos
Notes: Meeting Abstract: 549O -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Rona Denit Yaeger
    315 Yaeger